# Dianthus Therapeutics, Inc.: Form 8-K, filed Mar 5, 2025

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2025-03-05
- Accepted by EDGAR: Mar 5, 2025, 07:16 ET
- Period: 2025-03-04
- Accession: 0000950170-25-033075
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000095017025033075/dnth-20250304.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000095017025033075/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000095017025033075/dnth-20250304.htm

Filed Mar 5, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-033075. Last ingested by Listed: Nov 4, 2026, 16:45 ET. No prices; not investment advice.